MedTrace Logo

Lavender Sandalwood Aromatherapy Study

NCT07737392 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182

Last updated 2026-08-12

No results posted yet for this study

Summary

The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. The main questions this study aims to answer are:

* How does lavender sandalwood aromatherapy affect participants' mood during postpartum recovery after a cesarean section?
* Does lavender sandalwood aromatherapy help reduce pain during recovery?
* Does lavender sandalwood aromatherapy improve participants' overall satisfaction with their recovery experience? Researchers will compare participants who receive lavender-sandalwood aromatherapy with those who do not to determine whether it improves mood, reduces pain, and enhances patient satisfaction.

Participants will be asked to:

* Wear aromatherapy tabs on their gown for 24 hours.
* Have the aromatherapy tabs applied 24 hours after the cesarean section and removed 48 hours after the cesarean section.
* Complete surveys at 24 hours and 48 hours after the cesarean section. This will apply to both the control and intervention groups.

Conditions

  • Pain
  • Mood
  • Patient Satisfaction
  • Scheduled Cesarean Sections

Interventions

OTHER

Lavender-sandalwood aromatherapy tabs

The intervention used in this study consists of aromatherapy tabs infused with lavender and sandalwood essential oils. These aromatabs are administered to participants following their cesarean section procedures to evaluate their effectiveness in managing postoperative pain. The choice of lavender and sandalwood is based on their widely recognized calming and analgesic properties, with the goal of providing non-pharmacological support for pain relief. Participants in the experimental group will receive these aromatabs according to the study protocol, allowing for a clear comparison of outcomes between the aromatherapy intervention and the control group.

Sponsors & Collaborators

  • Memorial Hermann Health System

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-08-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07737392 on ClinicalTrials.gov